80 likes | 224 Views
Ward-based preparation of aseptic items. Responding to NPSA Patient safety alert 20. The actions required: 1. Undertake a risk assessment of injectable medicine procedures and products in all clinical areas to identify high risks, and develop an action plan to minimise them Key issues?
E N D
Ward-based preparation of aseptic items Responding to NPSA Patient safety alert 20
The actions required: 1 • Undertake a risk assessment of injectable medicine procedures and products in all clinical areas to identify high risks, and develop an action plan to minimise them • Key issues? • Multidisciplinary approach? • Cytotoxics and PN in pharmacy? • Organisation-wide therapeutic protocol for IV? • Dose calculation tools? • Double checking or ‘Smart’ pumps? • Documentation?
The actions required: 2 • Ensure there are up-to-date protocols and procedures for prescribing, preparing and administering injectable medicines in all clinical areas. • Key issues? • How is this being approached? • What about theatres?
The actions required: 3 • Ensure essential technical information on injectable medicines is available and accessible to healthcare staff in clinical areas at the point of use. • Key issues? • How will this be tackled? • Scope for collaboration? • Any experience with the Injectable Guide?
The actions required: 4 • Implement a “purchasing for safety” policy to promote procurement of injectable medicines with inherent safety features • Key issues? • Licensed v specials v locally made v ward-based preparation. Risks and benefits? • What is happening locally to develop this?
The actions required: 5 • Provide training for, and supervision of, all healthcare staff involved in prescribing, administering and monitoring injectable medicines. • Key issues? • What training is currently going on – in nursing, in medicine? • On what is the training based? • Do you have a training database? • Are you planning to use the NPSA competences?
The actions required: 6 • As part of the annual medicines management audit programme, healthcare organisations should include an audit of medication practice with injectable medicines • Key issues? • What audits would be useful/feasible to do? • Are any of the suggestions in the NPSA list in use?